MOOD LIGHT

Brand Owner (click to sort) Address Description
MOOD LITE SCENT SHOP, INC., THE 2614 NATIONAL PLACE GARLAND TX 75041 MOOD LIGHT;candle-powered diffuser lamp for use with fragrant oils;
MOOD-LITES WHITE, KATHRYN GOETZKE 25 1/2 Eastern Avenue Annapolis MD 21403 MOOD-LIGHT;Light Bulbs;
MOODLIGHT Monsieur Igor BASCHET 14 route du Village CH-1066 EPALINGES Switzerland MOOD LIGHT;Jewelry articles namely necklaces, neck chains, collar jewelry, bracelets, earrings, rings, medals and medallions, brooches, cufflinks, tie clips; precious stones, pearls and precious metals and imitations thereof; key rings and key chains and decorative key fobs; decorative objects made from or coated with semi-precious stones or metals, or imitations thereof namely jewelry cases, jewelry boxes, key chains for use as jewelry, shoe jewelry, hat jewelry, jewelry for the head, body jewelry; decorative articles in the nature of charms for collar jewelry and bracelet, charms for key rings; boxes of precious metal; works of art made of silver; identity plates made of precious metals; key rings comprised of split rings with decorative trinkets or fobs of precious metals;
MOODLIGHT ADC SOLUTIONS AUTO 2975 Redhill Ave., Ste. 100 Costa Mesa CA 92626 MOOD LIGHT;Automotive accessories, namely, gear shift knobs, ash trays and interior accent lights for motor vehicles;
MOODLIGHT HATCHBEAUTY AGENCY Suite 300 10951 Pico Blvd. Los Angeles CA 90064 MOOD LIGHT;Hair care products, namely, hair styling preparations, hair care preparations and non-medicated hair serums;
MOODLIGHT Elaboration, Inc. 250 Natural Bridges Drive Santa Cruz CA 95060 MOOD LIGHT;Software as a service (SAAS) featuring software for use in sentiment, linguistic, and cognitive classification, categorization, and analysis; Software as a service (SAAS) featuring software that integrates natural language processing, computational linguistics, information retrieval, and machine learning; Software as a service (SAAS) featuring software that uses a cognitive computing for understanding and responding to human speech and text inquiries; Software as a Service (SAAS) service featuring software that integrates digital artificial intelligence agents and bots; Software as a service (SAAS) featuring software for use in natural language understanding and processing; Software as a service (SAAS) featuring software for analysis of language, discourse, sentiment, emotion, thought, bias, mood, belief, and opinion analysis; Development of software applications for use in speech and text recognition and analysis and analysis of user behavior; Computer services, namely, application service provider featuring application programming interfaces (APIs) software;
MOODLITE MOODLITE SYSTEMS, INC. 2501 27TH AVENUE, F-8 VERO BEACH FL 32960 MOOD LIGHT;INDIRECT ELECTRIC LIGHTING FIXTURES FOR REAL AND ARTIFICIAL PLANTS AND STATUARY;
MOODLITE HENMARC CORPORATION 945 TREASURE LANE VERO BEACH FL 32963 MOOD LIGHT;INDIRECT ELECTRIC LIGHTING FIXTURES FOR REAL AND ARTIFICIAL PLANTS AND STATUARY;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to androgen receptor targeting agents (ARTA) which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The selective androgen receptor modulators (SARM) are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example conditions associated with Androgen Decline in Aging Male (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia, osteoporosis, benign prostate hyperplasia, alterations in mood and cognition and prostate cancer; c) treatment of conditions associated with Androgen Decline in Female (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, alterations in cognition and mood, depression, anemia, hair loss, obesity, endometriosis, breast cancer, uterine cancer and ovarian cancer; d) treatment and/or prevention of chronic muscular wasting; e) decreasing the incidence of, halting or causing a regression of prostate cancer; f) oral androgen relacement and/or other clinical therpauetic and/or diagnostic areas.